Category
14 stories · page 1 of 2
Ingredients
Salmon-DNA serums and injections are the skincare story of the moment. The best evidence is real, but it mostly concerns injected products and wound healing, not the serum on your shelf.
Aesthetics
Exosome serums and treatments promise regeneration. Early human studies are encouraging but small, and the US FDA says no exosome product is approved.
Aesthetics
Exosome science is promising, but clinic products do not share one composition, purity standard or evidence base. LCY separates topical, post-procedure and injected use.
Aesthetics
RF microneedling is rising as a collagen-remodelling treatment, but the FDA’s warning on serious complications makes device, settings and practitioner selection central.
Aesthetics
The 2026 aesthetics narrative increasingly places collagen stimulation and volumisation under one regenerative umbrella. LCY verdict: discuss indication, exact product, injector competence and complication planning—not category buzzwords.
Aesthetics
The neck is one of 2026’s busiest zones for devices, injectables and combination protocols. LCY verdict: the word evidence-based must attach to a specific protocol, not an entire procedure family.
Aesthetics
The 2026 literature is framing rapid-weight-loss facial change across multiple anatomical planes, not volume alone. LCY verdict: an anatomy-led staged plan—including the option to do nothing—is safer than a marketed one-size-fits-all package.
Aesthetics
The movement favours subtle plans that preserve expression and individuality. It is a strong consultation signal, not proof that one named technique is safer. A mechanism, a small case series, a controlled trial and real-world safety are different evidence levels; product identity and route matter.
Aesthetics
Different materials are marketed side by side as regenerative, although their sources, manufacturing, routes, standardisation and evidence are fundamentally different. A mechanism, a small case series, a controlled trial and real-world safety are different evidence levels; product identity and route matter.
Aesthetics
High-frequency ultrasound may help visualise vessels and previous filler, but equipment cannot replace anatomy knowledge, training or complication readiness. A mechanism, a small case series, a controlled trial and real-world safety are different evidence levels; product identity and route matter.
Aesthetics
Large reviews and current labeling support an association signal, but they do not prove one direct mechanism for every case or justify stopping treatment without a prescriber.
Aesthetics
At-home LED evidence is indication-, device- and protocol-specific: selected acne studies do not validate every rejuvenation claim.
